- ISSN: 0929-8673
- E-ISSN: 1875-533X
-
s Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer
- Source: Current Medicinal Chemistry, Volume 31, Issue 8, Mar 2024, p. 1040 - 1043
-
- 01 Mar 2024
- Previous Article
- Table of Contents
- Next Article
Abstract
The application describes the synthesis of 1H-pyrazolo[4,3-H]quinazoline compounds for treating cell proliferation dysfunction and is a broad-spectrum and strongly- active inhibitor for a cell cyclin-dependent kinase (CDK).
© Bentham Science Publishers
